Trial Leaders/Researchers:
Amir Goldkorn, M.D.
Other Trial Staff:
Ramona Lujan, R.N., Jiayi Jiang, D.M., Lagrimas Ilagan, D.M., Gina Tse, R.N., Xiomara Menendez, R.N., Noureddine Miloud, D.M., Honorina Enright, D.M., America Casillas-Lopez, Coordinator, Pritesh Chaudhari, D.M., Kristy Watkins, R.N.
|
|
| | Requirement |
| 1 | All cancer patients >18 years of age diagnosed with a solid tumor (i.e., non-leukemic) malignancy encountered at their regularly scheduled appointments will be eligible. These will include lymphomas and myelomas (only leukemias will be excluded). |
| 2 | At the conclusion of their encounters with their oncology care provider, the patient will be informed briefly about the purpose of the study and asked if he/she would be willing to provide consent for the additional single-stick venipuncture to be done at the time of other laboratory blood draws. |
| 3 | Patients will be told that their participation is completely voluntary, and that their decision will in no way impact their care at USC. |
| 4 | Phycians or research coordinators will consent and register patients in café and will provide the registration confirmation and informed consent to the PI |
